CD8A and primary cutaneous T-cell non-Hodgkin lymphoma: While CD103+ CD8 TRM reportedly contribute to the antitumor immunity with the production of IFNγ and granzymes in multiple solid cancers, benign T cells in CTCL lesions possess less TRM phenotype with Th2-biased suppressive property.